These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


271 related items for PubMed ID: 22407812

  • 1. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
    Mertens-Talcott SU, Noratto GD, Li X, Angel-Morales G, Bertoldi MC, Safe S.
    Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
    [Abstract] [Full Text] [Related]

  • 2. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
    Chintharlapalli S, Papineni S, Lei P, Pathi S, Safe S.
    BMC Cancer; 2011 Aug 24; 11():371. PubMed ID: 21864401
    [Abstract] [Full Text] [Related]

  • 3. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.
    Liu X, Jutooru I, Lei P, Kim K, Lee SO, Brents LK, Prather PL, Safe S.
    Mol Cancer Ther; 2012 Jul 24; 11(7):1421-31. PubMed ID: 22553354
    [Abstract] [Full Text] [Related]

  • 4. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
    Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S.
    Cancer Res; 2007 Nov 15; 67(22):11001-11. PubMed ID: 18006846
    [Abstract] [Full Text] [Related]

  • 5. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.
    Pathi SS, Jutooru I, Chadalapaka G, Sreevalsan S, Anand S, Thatcher GR, Safe S.
    Mol Cancer Res; 2011 Feb 15; 9(2):195-202. PubMed ID: 21156786
    [Abstract] [Full Text] [Related]

  • 6. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis.
    Noratto GD, Jutooru I, Safe S, Angel-Morales G, Mertens-Talcott SU.
    Mol Nutr Food Res; 2013 Sep 15; 57(9):1638-48. PubMed ID: 23471840
    [Abstract] [Full Text] [Related]

  • 7. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
    Gandhy SU, Kim K, Larsen L, Rosengren RJ, Safe S.
    BMC Cancer; 2012 Nov 30; 12():564. PubMed ID: 23194063
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.
    Li X, Mertens-Talcott SU, Zhang S, Kim K, Ball J, Safe S.
    Endocrinology; 2010 Jun 30; 151(6):2462-73. PubMed ID: 20382698
    [Abstract] [Full Text] [Related]

  • 9. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
    Chintharlapalli S, Papineni S, Abdelrahim M, Abudayyeh A, Jutooru I, Chadalapaka G, Wu F, Mertens-Talcott S, Vanderlaag K, Cho SD, Smith R, Safe S.
    Int J Cancer; 2009 Oct 15; 125(8):1965-74. PubMed ID: 19582879
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation.
    Banerjee N, Talcott S, Safe S, Mertens-Talcott SU.
    Breast Cancer Res Treat; 2012 Nov 15; 136(1):21-34. PubMed ID: 22941571
    [Abstract] [Full Text] [Related]

  • 11. The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.
    Sreevalsan S, Safe S.
    Mol Cancer Ther; 2013 Nov 15; 12(11):2483-93. PubMed ID: 24030632
    [Abstract] [Full Text] [Related]

  • 12. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a.
    Li W, Liu M, Xu YF, Feng Y, Che JP, Wang GC, Zheng JH.
    Oncol Rep; 2014 Jan 15; 31(1):117-24. PubMed ID: 24173369
    [Abstract] [Full Text] [Related]

  • 13. Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells.
    Chadalapaka G, Jutooru I, Burghardt R, Safe S.
    Mol Cancer Res; 2010 May 15; 8(5):739-50. PubMed ID: 20407012
    [Abstract] [Full Text] [Related]

  • 14. Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors.
    Nair V, Pathi S, Jutooru I, Sreevalsan S, Basha R, Abdelrahim M, Samudio I, Safe S.
    Carcinogenesis; 2013 Dec 15; 34(12):2870-9. PubMed ID: 23803693
    [Abstract] [Full Text] [Related]

  • 15. Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
    Kim K, Chadalapaka G, Pathi SS, Jin UH, Lee JS, Park YY, Cho SG, Chintharlapalli S, Safe S.
    Mol Cancer Ther; 2012 Sep 15; 11(9):1852-62. PubMed ID: 22752225
    [Abstract] [Full Text] [Related]

  • 16. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.
    Jutooru I, Chadalapaka G, Abdelrahim M, Basha MR, Samudio I, Konopleva M, Andreeff M, Safe S.
    Mol Pharmacol; 2010 Aug 15; 78(2):226-36. PubMed ID: 20488920
    [Abstract] [Full Text] [Related]

  • 17. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.
    Chintharlapalli S, Papineni S, Ramaiah SK, Safe S.
    Cancer Res; 2007 Mar 15; 67(6):2816-23. PubMed ID: 17363604
    [Abstract] [Full Text] [Related]

  • 18. The transcriptional repressor ZBTB4 regulates EZH2 through a MicroRNA-ZBTB4-specificity protein signaling axis.
    Yang WS, Chadalapaka G, Cho SG, Lee SO, Jin UH, Jutooru I, Choi K, Leung YK, Ho SM, Safe S, Kim K.
    Neoplasia; 2014 Dec 15; 16(12):1059-69. PubMed ID: 25499219
    [Abstract] [Full Text] [Related]

  • 19. Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.
    Chadalapaka G, Jutooru I, Safe S.
    Carcinogenesis; 2012 Apr 15; 33(4):886-94. PubMed ID: 22334592
    [Abstract] [Full Text] [Related]

  • 20. Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78.
    Cai Y, Zheng Y, Gu J, Wang S, Wang N, Yang B, Zhang F, Wang D, Fu W, Wang Z.
    Cell Death Dis; 2018 May 25; 9(6):636. PubMed ID: 29802332
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.